AZZ
AZZ Inc.
Latest News for AZZ
Zymeworks ($ZYME) stock rallied 29% on Monday, after the clinical-stage biotechnology company announced positive Phase 3 trial results for its gast......
In a report released today, from Jefferies maintained a Buy rating on Jazz Pharmaceuticals, with a price target of $225.00. In addition to Jefferie......
All of the top stock market stories are ready to go in the TipRanks daily wrap-up. ...
Jazz Pharmaceuticals stock gained on Monday after the company posted positive clinical trial data. ...
Jazz Pharmaceuticals ( ($JAZZ) ) has issued an announcement. On November 17, 2025, Jazz Pharmaceuticals announced positive results from the Phase 3......
Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Jazz Pharmaceuticals yesterday and set a price target of $230.00. The ......
In a report released on November 10, Leonid Timashev from RBC Capital maintained a Buy rating on Jazz Pharmaceuticals, with a price target of $155.......
News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AZZ | $102.72 | +3.2% | 350.17K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |